Barclays adjusted its price target for Labcorp on June 24, 2025.
2 reports, 1 independent
Updated Oct 6
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays adjusted its price target for Labcorp on June 24, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Barclays upgraded LabCorp's rating to Overweight; company is shedding transition services agreements.1 source
- Barclays adjusted price target for Labcorp on 2025-06-24.
Keep exploring
The entities involved
Related events
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.
- On July 11, 2025, a rating action was taken on Hewlett Packard Enterprise and Barclays, including raising the price target and maintaining an overweight rating.
- Barclays lifted its share target for Strategy on October 1, 2026.
- ISI (Twist Bioscience) was listed on the Nasdaq stock exchange, and Barclays raised its price target on the company on July 9, 2026.
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
Coverage
Newest first; wire copies grouped- financialcontent.com
- Unknown outlet